Navigation Links
ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
Date:5/22/2008

al tubular level) was well defined, in a separate study of healthy volunteers. Multaq(R) showed a rate of pro-arrhythmia similar to placebo and no excess of hospitalizations for congestive heart failure. There was a similar rate of study drug discontinuation between the 2 study groups.

ATHENA, was the largest double blind randomized study in patients with atrial fibrillation, and conducted in more than 550 sites in 37 countries and enrolled a total of 4,628 patients. The landmark ATHENA trial is the first morbidity-mortality study as part of the Multaq(R) phase III clinical development program, which also included five other multinational clinical studies: an initial study, ANDROMEDA, conducted in patients with severe congestive heart failure and a recent decompensation, and a total of 4 international studies in atrial fibrillation: EURIDIS/ADONIS, ERATO, and the ongoing DIONYSOS trial.

Atrial fibrillation is a major cause of hospitalization and mortality and affects about 2.5 million people in the United States, as well as 4.5 million people in the European Union and is emerging as a growing public health concern due to an aging population. Patients suffering from atrial fibrillation have twice the risk of death, an increased risk of stroke and cardiovascular complications, including congestive heart failure.

About Atrial Fibrillation / Flutter

Atrial fibrillation is a major cause of hospitalization and mortality and affects about 2.5 million people in the USA and 4.5 million people in the European Union. The Atrial Fibrillation Foundation expects the number of patients with AF to double in the next 20 years. Without appropriate management, atrial fibrillation can lead to serious complications, such as stroke and congestive heart failure.

AF is a condition in which the upper chambers of the heart beat in an uncoordinated and disorganised fashion, resulting in an irregular and fast heart rhythm (i.e. an irregular heartbeat). Atrial
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
2. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
3. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
4. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
5. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
6. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
7. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
8. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
9. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
10. Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting
11. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Holdings, Inc. today announced that it has been na...Technology Council (NJTC), a 1,200-member non-prof...tworking opportunities, information and advocacy f...earned the award based on criteria including marke... , , "We are delighted that the New Jersey ...
(Date:11/20/2008)... The following is being released by Center for Hea...AIDS Day Audio Media Conference , , WHEN:... EST , Call-in number: 1-800-949-8476 , RSVP...1xe41i2yre8rs , , WHY: With new HIV infe... treatment worldwide, advocates are calling on the...
(Date:11/20/2008)...GlaxoSmithKline (NYSE: ...and Drug Administration (FDA) granted accelerated ...atment of thrombocytopenia in patients with chroni...P) who have had an insufficient response to cortic...roval is a significant milestone for PROMACTA and ...
(Date:11/20/2008)...ire-FirstCall/ -- Arpida (SWX:,ARPN) announced to...ee of the,U.S. Food and Drug Administration (FDA)...enous iclaprim, an antibiotic currently in develop...ed skin and skin structure infections,(cSSSIs), i...phylococcus,aureus (MRSA). , Arpida remain...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Direct Relief International Aims California Fire Response at Health Concerns 4445 1Direct Relief International Aims California Fire Response at Health Concerns 4445 2Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion 4442 1Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion 4442 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 1IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 3Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County 4440 1Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County 4440 2
....Y.--(BUSINESS WIRE)--Jun 4, 2007 - Acorda,Therape... the,Company presented a "meta-analysis" or combin...R in multiple sclerosis during a,poster session at...,in MS (ACTRIMS) Meeting in Washington, D.C. on Sa...onsistent Improvement in Walking,Speed on the Time...
...SINESS WIRE)--Jun 4, 2007 - Cytogen Corporation,(N...trials,demonstrating that QUADRAMET (samarium Sm-1...d to prostate cancer patients who are also,receivi...-Aventis).,Clinical data also support further eval...t of prostate cancer in a Phase 2 program.,The res...
Other Medicine Technology:Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 2New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 3New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 5New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 6New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 7
(Date:11/22/2008)...0 don,t do enough to protect themselves from strok...ealthDay News) -- It,s one of medicine,s mantras: ...ower it will have a dramatic impact on your risk o...ent of people with high blood pressure still aren,...g to a U.S. Centers for Disease Control and Preven...
(Date:11/21/2008)...NTY, Calif., Nov. 21 Album Creativ...rm, launches a new program offering big brand mark...ken the large, expensive ad agency process and ser...a very hands-on approach," says Matt Parker, Creat...combines experience and proven brand-building tech...
(Date:11/21/2008)...ASSEE, Fla. -- A Florida State University College ... discovered an important new layer of regulation i...reater understanding of the way cancer begins. , ...es at the College of Medicine, said the findings w... and could lead to the design of new drugs that ki...
(Date:11/21/2008)...iz., Nov. 21 The Provide...nnounced that Craig A. Norris, the Company,s,Chie...pany,s Board of,Directors. Mr. Norris, appointme...nation of Steven I. Geringer and returns the board...y committee of the Board. , Mr. Norris, age...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3
...rkable for its ability to live in the strong acid ...ccoli is powerful against the bacterium that is li.../ It's now well established that this microbe is r...Clearing it with antibiotics is an important form ...
...ggest that, some women who develop gestational dia...en with certain chromosomal abnormalities However,...tself a risk factor for these types of defects sin...l before gestational diabetes typically develops./...
... study on seedless green grapes which caused a sal...x Western states last summer and fall. Researchers...nella serotype senftenberg// most often found in m...to people through grapes. Dr.Alicia, at the Intern...
...utting their lives at risk because they fail to ex...embarrassed to consult their general practitioner ... their argument on a case study involving a young...t and suffered minor injuries. Four days later he ...
Other Medicine News:Health News:Gestational Diabetes linked to Chromosomal defici 2Health News:Grapes, Melons Implicated in Outbreaks 2Health News:Patients with testicular cancer dying through unfamiliarity 2